Pfizer Inc.
PFE
$24.86
$0.291.18%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
06/29/2025 | 03/30/2025 | 12/31/2024 | 09/29/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 13.54% | 11.65% | 6.84% | -12.76% | -28.30% |
Total Other Revenue | -- | -- | -- | -55.35% | -55.39% |
Total Revenue | 13.54% | 11.65% | 6.84% | -12.76% | -28.31% |
Cost of Revenue | 5.91% | -0.66% | -7.72% | -55.19% | -32.39% |
Gross Profit | 16.51% | 16.61% | 13.04% | 13.04% | -26.58% |
SG&A Expenses | -0.64% | 2.87% | 6.57% | 4.24% | 5.59% |
Depreciation & Amortization | 0.63% | 5.08% | 11.68% | 12.99% | 19.36% |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 0.98% | 0.88% | 0.50% | -25.29% | -12.80% |
Operating Income | 68.01% | 59.12% | 30.71% | 39.07% | -59.53% |
Income Before Tax | 353.01% | 512.40% | 658.32% | -62.52% | -118.28% |
Income Tax Expenses | 85.31% | 66.82% | 97.49% | -346.67% | -230.08% |
Earnings from Continuing Operations | 520.13% | 3,208.66% | 270.50% | -59.02% | -111.90% |
Earnings from Discontinued Operations | 1,300.00% | 176.19% | 173.33% | -269.23% | 90.00% |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -33.33% | 14.71% | 20.51% | 15.79% | 36.17% |
Net Income | 514.34% | 2,651.13% | 279.00% | -59.44% | -112.09% |
EBIT | 68.01% | 59.12% | 30.71% | 39.07% | -59.53% |
EBITDA | 42.14% | 38.37% | 24.39% | 30.86% | -45.78% |
EPS Basic | 511.31% | 2,595.87% | 275.63% | -59.80% | -112.06% |
Normalized Basic EPS | 60.70% | 41.73% | 4.91% | 15.23% | -64.73% |
EPS Diluted | 504.53% | 2,229.80% | 297.64% | -59.43% | -112.44% |
Normalized Diluted EPS | 60.45% | 41.71% | 5.43% | 17.12% | -64.22% |
Average Basic Shares Outstanding | 0.34% | 0.35% | 0.37% | 0.43% | 0.51% |
Average Diluted Shares Outstanding | 0.61% | 0.49% | 0.30% | -0.37% | -0.94% |
Dividend Per Share | 2.41% | 2.42% | 2.44% | 2.45% | 2.47% |
Payout Ratio | 1.19% | 1.04% | -0.73% | 1.54% | -9.52% |